Dominant, toxic gain-of-function mutations ingarslead to non-cell autonomous neuropathology
Open Access
- 13 May 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 24 (15) , 4397-4406
Abstract
Charcot–Marie–Tooth (CMT) neuropathies are collectively the most common hereditary neurological condition and a major health burden for society. Dominant mutations in the gene GARS, encoding the ubiquitous enzyme, glycyl-tRNA synthetase (GlyRS), cause peripheral nerve degeneration and lead to CMT disease type 2D. This genetic disorder exemplifies a recurring motif in neurodegeneration, whereby mutations in essential, widely expressed genes have selective deleterious consequences for the nervous system. Here, using novel Drosophila models, we show a potential solution to this phenomenon. Ubiquitous expression of mutant GlyRS leads to motor deficits, progressive neuromuscular junction (NMJ) denervation and pre-synaptic build-up of mutant GlyRS. Intriguingly, neuronal toxicity is, at least in part, non-cell autonomous, as expression of mutant GlyRS in mesoderm or muscle alone results in similar pathology. This mutant GlyRS toxic gain-of-function, which is WHEP domain-dependent, coincides with abnormal NMJ assembly, leading to synaptic degeneration, and, ultimately, reduced viability. Our findings suggest that mutant GlyRS gains access to ectopic sub-compartments of the motor neuron, providing a possible explanation for the selective neuropathology caused by mutations in a widely expressed gene.Keywords
This publication has 56 references indexed in Scilit:
- Spinal muscular atrophy: The role of SMN in axonal mRNA regulationBrain Research, 2012
- Glial-Derived Prodegenerative Signaling in the Drosophila Neuromuscular SystemNeuron, 2011
- An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutationsMolecular and Cellular Neuroscience, 2011
- Neurodegenerative models in Drosophila: Polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosisNeurobiology of Disease, 2010
- Compound Heterozygosity for Loss-of-Function Lysyl-tRNA Synthetase Mutations in a Patient with Peripheral NeuropathyThe American Journal of Human Genetics, 2010
- GARS axonopathy: not every neuron's cup of tRNATrends in Neurosciences, 2010
- A Major Determinant for Binding and Aminoacylation of tRNAAla in Cytoplasmic Alanyl-tRNA Synthetase Is Mutated in Dominant Axonal Charcot-Marie-Tooth DiseaseThe American Journal of Human Genetics, 2010
- Axonal transport and the delivery of pre-synaptic componentsCurrent Opinion in Neurobiology, 2008
- Charcot–Marie–Tooth disease-associated mutant tRNA synthetases linked to altered dimer interface and neurite distribution defectProceedings of the National Academy of Sciences, 2007
- Long-range structural effects of a Charcot–Marie–Tooth disease-causing mutation in human glycyl-tRNA synthetaseProceedings of the National Academy of Sciences, 2007